Log in

NYSE:NUS - Nu Skin Enterprises Stock Price, Forecast & News

$30.45
+0.48 (+1.60 %)
(As of 02/16/2020 04:00 PM ET)
Add
Today's Range
$30.06
Now: $30.45
$31.77
50-Day Range
$29.97
MA: $37.98
$42.56
52-Week Range
$29.09
Now: $30.45
$64.90
Volume1.50 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E Ratio9.79
Dividend YieldN/A
BetaN/A
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryPersonal Products
SectorN/A
CUSIP67018T10
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees4,900
Next Earnings Date5/5/2020 (Estimated)
OptionableOptionable

Receive NUS News and Ratings via Email

Sign-up to receive the latest news and ratings for NUS and its competitors with MarketBeat's FREE daily newsletter.


Nu Skin Enterprises (NYSE:NUS) Frequently Asked Questions

What is Nu Skin Enterprises' stock symbol?

Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."

How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises?

Nu Skin Enterprises announced a quarterly dividend on Wednesday, February 12th. Investors of record on Friday, February 28th will be paid a dividend of $0.375 per share on Wednesday, March 11th. This represents a $1.50 annualized dividend and a yield of 4.93%. The ex-dividend date is Thursday, February 27th. This is a boost from Nu Skin Enterprises's previous quarterly dividend of $0.37. View Nu Skin Enterprises' Dividend History.

How were Nu Skin Enterprises' earnings last quarter?

Nu Skin Enterprises, Inc. (NYSE:NUS) announced its quarterly earnings data on Wednesday, February, 12th. The company reported $0.72 EPS for the quarter, hitting the Thomson Reuters' consensus estimate of $0.72. The business earned $583.36 million during the quarter, compared to analysts' expectations of $582.49 million. The company's revenue was down 14.6% on a year-over-year basis. During the same period in the prior year, the firm earned $1.05 earnings per share. View Nu Skin Enterprises' Earnings History.

When is Nu Skin Enterprises' next earnings date?

Nu Skin Enterprises is scheduled to release their next quarterly earnings announcement on Tuesday, May 5th 2020. View Earnings Estimates for Nu Skin Enterprises.

What guidance has Nu Skin Enterprises issued on next quarter's earnings?

Nu Skin Enterprises updated its FY20 earnings guidance on Wednesday, February, 12th. The company provided earnings per share (EPS) guidance of $2.00-2.40 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.31. The company issued revenue guidance of $2.17-2.30 billion, compared to the consensus revenue estimate of $2.47 billion.

What price target have analysts set for NUS?

7 Wall Street analysts have issued 1-year target prices for Nu Skin Enterprises' shares. Their forecasts range from $30.00 to $70.00. On average, they expect Nu Skin Enterprises' stock price to reach $44.71 in the next year. This suggests a possible upside of 46.8% from the stock's current price. View Analyst Price Targets for Nu Skin Enterprises.

What is the consensus analysts' recommendation for Nu Skin Enterprises?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last year. There are currently 1 sell rating, 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Nu Skin Enterprises.

What are Wall Street analysts saying about Nu Skin Enterprises stock?

Here are some recent quotes from research analysts about Nu Skin Enterprises stock:
  • 1. According to Zacks Investment Research, "Nu Skin’s shares have underperformed the industry in the past six months. Headwinds in Mainland China, a soft view for 2020 and currency fluctuations are prime deterrents. The recently completed 100-day government campaign in Mainland China to inspect offerings of the nutrition and direct sales industry led to adversities like limited sales meetings. This took a toll on the company’s third-quarter 2019 results, with revenues and earnings declining year over year. The company also issued a soft view for the fourth quarter and 2020, wherein adverse impacts from currency movements are likely to persist. Nevertheless, the company is on track with product launches and programs to strengthen sales leaders in Mainland China. Also, the company is committed toward boosting customer base, which grew 4% in the third quarter." (11/11/2019)
  • 2. Pivotal Research analysts commented, "We suspect that NUS management has taken an axe to the outlook to avoid having to cut again." (8/7/2019)

Has Nu Skin Enterprises been receiving favorable news coverage?

Media coverage about NUS stock has been trending somewhat positive this week, according to InfoTrie Sentiment. The research group ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Nu Skin Enterprises earned a media sentiment score of 2.0 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Nu Skin Enterprises.

Are investors shorting Nu Skin Enterprises?

Nu Skin Enterprises saw a increase in short interest during the month of January. As of January 31st, there was short interest totalling 1,800,000 shares, an increase of 13.9% from the January 15th total of 1,580,000 shares. Based on an average daily trading volume, of 428,700 shares, the days-to-cover ratio is presently 4.2 days. Currently, 3.4% of the shares of the company are sold short. View Nu Skin Enterprises' Current Options Chain.

Who are some of Nu Skin Enterprises' key competitors?

What other stocks do shareholders of Nu Skin Enterprises own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nu Skin Enterprises investors own include Alibaba Group (BABA), General Electric (GE), Marathon Petroleum (MPC), Herbalife Nutrition (HLF), Baidu (BIDU), Alphabet (GOOG), Netflix (NFLX), Tesla (TSLA), Booking (BKNG) and Caterpillar (CAT).

Who are Nu Skin Enterprises' key executives?

Nu Skin Enterprises' management team includes the folowing people:
  • Mr. Steven J. Lund, Exec. Chairman (Age 66)
  • Mr. Ritch N. Wood, CEO & Director (Age 53)
  • Mr. Ryan S. Napierski, Pres (Age 45)
  • Mr. Mark H. Lawrence, Exec. VP & CFO (Age 49)
  • Dr. Joseph Y. Chang, Exec. VP of Product Devel. & Chief Scientific Officer (Age 66)

Who are Nu Skin Enterprises' major shareholders?

Nu Skin Enterprises' stock is owned by a number of of retail and institutional investors. Top institutional investors include AQR Capital Management LLC (3.65%), Renaissance Technologies LLC (2.66%), State Street Corp (2.44%), Bank of New York Mellon Corp (1.65%), Goldman Sachs Group Inc. (1.35%) and Prudential Financial Inc. (0.95%). Company insiders that own Nu Skin Enterprises stock include D Matthew Dorny, Edwina D Woodbury, Foulis Greg, Joseph Y Chang, Mark H Lawrence, Neil H Offen, Pisano R Thomas, Ryan S Napierski and Steven Lund. View Institutional Ownership Trends for Nu Skin Enterprises.

Which major investors are selling Nu Skin Enterprises stock?

NUS stock was sold by a variety of institutional investors in the last quarter, including Martingale Asset Management L P, Cubist Systematic Strategies LLC, Acadian Asset Management LLC, Schroder Investment Management Group, Russell Investments Group Ltd., Los Angeles Capital Management & Equity Research Inc., Spark Investment Management LLC and Franklin Resources Inc.. View Insider Buying and Selling for Nu Skin Enterprises.

Which major investors are buying Nu Skin Enterprises stock?

NUS stock was bought by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, Bank of New York Mellon Corp, Bank of America Corp DE, Mackay Shields LLC, Goldman Sachs Group Inc., Panagora Asset Management Inc., UBS Group AG and MUFG Securities EMEA plc. View Insider Buying and Selling for Nu Skin Enterprises.

How do I buy shares of Nu Skin Enterprises?

Shares of NUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Nu Skin Enterprises' stock price today?

One share of NUS stock can currently be purchased for approximately $30.45.


MarketBeat Community Rating for Nu Skin Enterprises (NYSE NUS)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  480 (Vote Outperform)
Underperform Votes:  455 (Vote Underperform)
Total Votes:  935
MarketBeat's community ratings are surveys of what our community members think about Nu Skin Enterprises and other stocks. Vote "Outperform" if you believe NUS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NUS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/16/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel